ARCHIVES

Watson Steps Down As Chancellor at Cold Spring Harbor Laboratory.

This article is from The Cancer Letter archive.

Vol. 33 No. 39 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

NCI Grant Boosts UCLA Bladder Cancer Project

October 25, 2002

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

NCCN Admits Two New Member Institutions

March 22, 2013

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010